Hormone replacement therapy and accuracy of mammographic screening

Hurley, 1992, The benefits and risks of mammographic screening for breast cancer, Epidemiol Rev, 14, 101, 10.1093/oxfordjournals.epirev.a036082 Kerlikowske, 1996, Effect of age, breast density and family history on the sensitivity of first screening mammography, JAMA, 276, 33, 10.1001/jama.1996.03540010035027 Kerlikowske, 1993, Positive predictive value of screening mammography by age and family history of breast cancer, JAMA, 270, 2444, 10.1001/jama.1993.03510200050031 Peer, 1996, Age-specific sensitivities of mammographic screening for breast cancer, Breast Cancer Res Treat, 38, 153, 10.1007/BF01806669 Schouten, 1997, Hormone replacement therapy and high incidence of breast cancer between mammographic screens, Lancet, 349, 1104, 10.1016/S0140-6736(05)62329-X Ma, 1992, Case-control study of factors associated with failure to detect breast cancer by mammography, J Nad Cancer Inst, 84, 781, 10.1093/jnci/84.10.781 van Gils, 1998, Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, the Netherlands, J Epidemiol Community Health, 52, 267, 10.1136/jech.52.4.267 Laya, 1996, Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography, J Nad Cancer Inst, 88, 643, 10.1093/jnci/88.10.643 Litherland, 1997, The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme, Clin Radial, 52, 276, 10.1016/S0009-9260(97)80053-0 Thurfjell, 1997, Screening mammography: sensitivity and specificity in relation to hormone replacement therapy, Radiology, 203, 339, 10.1148/radiology.203.2.9114085 Séradour, 1999, Hormone replacement therapy and screening mammography: analysis of the results of the du Rhone programme, J Med Screen, 6, 99, 10.1136/jms.6.2.99 Rosenberg, 1998, Effects of age, breast density, ethnicity and estrogen replacement therapy on the sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico, Radiology, 209, 511, 10.1148/radiology.209.2.9807581 Litherland, 1999, The effect of hormone replacement therapy on the sensitivity of screening mammograms, Clin Radial, 54, 285, 10.1016/S0009-9260(99)90555-X Cohen, 1997, Effect of hormone replacement therapy on cancer detection by mammography, Lancet, 349, 1624, 10.1016/S0140-6736(05)61662-5 MacLennan, 1995, Changes in the use of hormone replacement therapy in South Australia, Med J Aust, 162, 420, 10.5694/j.1326-5377.1995.tb139971.x Beral, 1997, Hormone replacement therapy and high incidence of breast cancer between mammographic screens, Lancet, 349, 1103, 10.1016/S0140-6736(05)62328-8 Threlfall, 1997, Breast screening programme: should the interval between tests depend on age?, Lancet, 349, 472, 10.1016/S0140-6736(05)61182-8 Tabar, 1987, What is the optimum interval between mammographic screening examinations? An analysis on the latest results of the Swedish Two-County Breast Cancer Screening Trial, Br J Cancer, 55, 547, 10.1038/bjc.1987.112 1999 Kavanagh, 1999, Monitoring interval cancers in an Australian mammographic screening program, J Med Screen, 6, 139, 10.1136/jms.6.3.139 McNicholas, 1994, Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study, Am J Roentgenol, 163, 311, 10.2214/ajr.163.2.8037021 Bergkvist, 1989, Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment, Am J Epidemiol, 130, 503, 10.1093/oxfordjournals.aje.a115364 Leung, 1997, Mammographic density in women on postmenopausal hormone replacement therapy, Surgery, 122, 669, 10.1016/S0039-6060(97)90072-6 Rand, 1997, Mammography in women undergoing hormone replacement therapy. Possible effects revealed at routine examination, Acta Radial, 38, 228 Wald, 1995, UKCCR multicentre randomised controlled trial of one and two view mammography and breast cancer screening, BMJ, 311, 1189, 10.1136/bmj.311.7014.1189 Marugg, 1997, Mammographic changes in postmenopausal women on hormone replacement therapy, Eur Radial, 7, 749, 10.1007/BF02742938 Stomper, 1990, Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study, Radiology, 174, 487, 10.1148/radiology.174.2.2136958 Laya, 1995, Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern, Radiology, 196, 433, 10.1148/radiology.196.2.7617857 Persson, 1997, Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density, J Clin Oncol, 15, 3201, 10.1200/JCO.1997.15.10.3201 Berkowitz, 1990, Hormonal replacement therapy: mammographic manifestations, Radiology, 174, 199, 10.1148/radiology.174.1.2152982 Lundstrom, 1999, Mammographic breast density during hormone replacement therapy: differences according to treatment, Am J Obstet Gynecol, 181, 348, 10.1016/S0002-9378(99)70560-0 Shelley, 1995, Use of hormone replacement therapy by Melbourne women, Aust N Z J Public Health, 19, 387, 10.1111/j.1753-6405.1995.tb00391.x Salmon, 1995, HRT and breast cancer, Lancet, 346, 1702, 10.1016/S0140-6736(95)92864-2 Harding, 1996, Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit, BMJ, 312, 1646, 10.1136/bmj.312.7047.1646 Magnusson, 1996, Prognostic characteristics in breast cancers after hormone replacement therapy, Breast Cancer Res Treat, 38, 325, 10.1007/BF01806152 Holli, 1997, Hormone replacement therapy and the biological aggressiveness of breast cancer, Lancet, 350, 1704, 10.1016/S0140-6736(05)64308-5 1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer, Lancet, 350, 1047, 10.1016/S0140-6736(97)08233-0 Roubidoux, 1998, Breast cancer in women who undergo screening mammography: relationship of hormone replacement therapy to stage and detection method, Radiology, 208, 725, 10.1148/radiology.208.3.9722852 Brisson, 1988, Mammographic parenchymal features and breast cancer detection demonstration project, J Nad Cancer Inst, 80, 1534, 10.1093/jnci/80.19.1534 Harvey, 1997, Short-term cessation of hormone replacement therapy and improvement of mammographic specificity, J Natl Cancer Inst, 89, 1623, 10.1093/jnci/89.21.1623